Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prothymosin alpha pseudogene (ENSG00000259020) is a member of the human prothymosin alpha gene family, classified as a processed pseudogene. Unlike the functional PTMA gene, which encodes the immune-modulating protein prothymosin alpha, the pseudogene possesses sequence similarity but does not produce transcripts or functional protein in human tissues. Genetic studies show these pseudogenes typically lack deleterious mutations but have no evidence for active expression or biological activity. Thus, this locus is not recognized as a molecular target for therapy, drug development, or disease biology in humans.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prothymosin alpha pseudogene.